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General 
Commercially available chemicals and solvents were used without further purification, unless 
otherwise stated. Reactions were monitored by TLC (SiO2-60, F254, Merck). Purification by column 
chromatography was carried out using silica gel 60 (0.040-0.063 mm, Merck). NMR spectra were 
recorded on a Varian Gemini 2000 spectrometer in either CDCl3 (Bie & Berntsen) or D2O (Cambridge 
Isotope Laboratories). TMS was used as an internal standard for 1H spectra and the residual solvent peak 
of CDCl3 (77.16 ppm) for 13C spectra. The residual solvent peak of water (4.79 ppm) was used to 
calibrate 1H spectra recorded in D2O, and 1,4-dioxane (67.19 ppm) was used as internal standard for 13C 
spectra. MALDI-HRMS was recorded on an Ionspec 4.7 Ultima FT mass spectrometer, EI-MS on a 
Finnigan SSQ 710 instrument and ESI-HRMS on a Q-Star Pulsar hybrid QqTOF instrument. UV-VIS 
spectra were recorded on a Lambda 35 UV/VIS Spectrometer (Perkin Elmer) at 40 µM compound 
concentration in water. DCL building blocks were purified by HPLC (Dionex UltiMate 3000) using a 
Phenomenex Gemini 5u C18 150x100 mm column; 3 mL/min flow; an isocratic mixture of either 15% or 
20% acetonitrile in water (0-20 min) with 0.05% TFA as modifier. Library analysis was performed using 
a Phenomenex Luna 3u C18 250x4.6 mm column; 0.7 mL/min flow; a gradient of 10-12% acetonitrile in 
water (0-240 min), then 12-16% acetonitrile in water (240-360 min) with 0.05% TFA as modifier. 
 
Synthesis 
Synthesis of scaffolds 
N-(2-((2-aminoethyl)disulfanyl)ethyl)acridin-9-amine, Aa 
 
9-Chloroacridine (0.080 g, 0.37 mmol) and phenol (0.211 g, 2.25 mmol) were mixed and heated at 
80 °C for 30 min. N-(tert-Butyloxycarbonyl)cystamine hydrochloride[1] (0.119 g, 0.41 mmol) and Et3N 
(313 μL, 2.25 mmol) were added and the reaction mixture was stirred at 100 °C for 3 hrs, cooled to RT 
and the volatiles removed in vacuo. The residue was subjected to flash column chromatography 
(EtOAc/MeOH 6:1 v/v) to give the product as a yellow oil (89 mg, 55 %). 1H NMR (CDCl3, 300 MHz): δ 
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8.16 (d, J = 8.7 Hz, 2H), 8.03 (d, J = 9.0 Hz, 2H), 7.64 (t, J = 7.2 Hz, 2H), 7.36 (t, J = 7.2 Hz, 2H), 4.96 
(br. s, 1H), 4.14 (t, J = 6.3 Hz, 2H), 3.41 (q, J = 6.0 Hz, 2H), 3.01 (t, J = 6.0 Hz, 2H), 2.78 (t, J = 6.3 Hz, 
2H), 1.43 (s, 9H); 13C NMR (CDCl3, 75 MHz): δ 155.9, 151.7, 147.9, 130.6, 128.0, 123.6, 123.3, 117.1, 
79.8, 48.5, 39.5, 38.9, 38.5, 28.5; MALDI-HRMS: calcd. for C22H28N3O2S2+ 430.1618, found 430.1608. 
The yellow oil (0.067 g, 0.16 mmol) was dissolved in dry DCM (2.5 mL) and TFA (0.5 mL) was 
added. The reaction was stirred under argon for 40 min and concentrated to give the TFA salt of Aa in 
quantitative yield as a bright yellow thick oil, which was purified by HPLC (15% MeCN, Rt 12.5 min). 
1H NMR (D2O, 300 MHz): δ 7.94 (d, J = 8.4 Hz, 2H), 7.77 (t, J = 7.2 Hz, 2H), 7.33-7.40 (m, 4H), 4.14 (t, 
J = 6.3 Hz, 2H), 3.40 (t, J = 6.3 Hz, 1H), 3.30 (t, J = 6.3 Hz, 2H), 3.07 (t, J = 6.3 Hz, 2H), 3.01 (t, J = 6.3 
Hz, 1H), 2.90 (t, J = 6.3 Hz, 2H); 13C NMR (D2O, 75 MHz): δ 158.0, 139.5, 136.0, 125.1, 124.7, 118.9, 
112.4, 47.7, 38.1, 35.9, 33.9; MALDI-HRMS: calcd. for C17H20N3S2+ 330.1093, found 330.1081. 
 
N2,N6-Bis(2-((2-aminoethyl)disulfanyl)ethyl)pyridine-2,6-dicarboxamide, Ba2 
 
EDC hydrochloride (0.518g, 2.70 mmol), HOBt hydrate (0.365g, 2.70 mmol) and Et3N (0.37 mL, 
2.7 mmol) were added a solution of pyridine-2,6-dicarboxylic acid (0.205 g, 1.23 mmol) in dry DMF (15 
mL) under argon. N-(tert-Butyloxycarbonyl)cystamine[1] (0.620g, 2.26 mmol) was dissolved in dry DMF 
(10 mL) and added the reaction mixture on an ice bath. After stirring at RT for 23 hrs the DMF was 
concentrated and the residue was dissolved in EtOAc (100 mL). The organic phase was sequentially 
washed with water (2x 50 mL), 1 M hydrochloric acid (3x 50 mL), saturated NaHCO3 solution (3x 50 
mL) and brine (1x 50 mL). The organic phase was dried (MgSO4) and concentrated in vacuo.  
Purification by dry column chromatography (5-50% EtOAc in petroleum ether) gave the desired product 
as white foam (0.483g, 62 %). 1H NMR (CDCl3): δ 8.61 (br. s, 2H), 8.35 (d, J = 7.8 Hz, 2H), 8.03 (t, J = 
7.8 Hz, 1H), 5.16 (br s, 2H), 3.81 (q, J = 6.0 Hz, 4H), 3.48 (q, J = 6.0 Hz, 4H), 2.98 (t, J = 6.0 Hz, 4H), 
2.85 (t, J = 6.0 Hz, 4H), 1.43(s, 18H); 13C NMR (CDCl3): δ 164.0, 156.3, 148.8, 139.1, 125.1, 79.9, 39.5, 
38.8, 38.6, 38.3, 28.5; MALDI-HRMS: calcd. for C25H41N5NaO6S4+ 658.1832, found 658.1810. 
The Boc-protected target compound (0.256 g, 0.40 mmol) was deprotected as described for Aa to 
give the TFA salt of Ba3 in quantitative yield as white foam, which was purified by HPLC (20% MeCN, 
Rt 6.6 min). 1H NMR (D2O): δ 8.20-8.10 (m, 3H), 3.79 (t, J = 6.3 Hz, 4H), 3.36 (t, J = 6.3 Hz, 4H), 2.98-
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3.05 (2x t, J = 6.3 Hz, 8H); 13C NMR (D2O): δ 166.3, 148.4, 140.5, 125.6, 38.9, 38.4, 37.0, 34.3; 
MALDI-HRMS: calcd. for C15H25N5NaO2S4+: 458.0783, found 458.0780. 
 
N1,N3,N5-Tris(2-((2-aminoethyl)disulfanyl)ethyl)benzene-1,3,5-tricarboxamide, Ca3 
 
EDC hydrochloride (0.810g, 4.23 mmol), HOBt hydrate (0.571g, 4.23 mmol) and Et3N (0.59 mL, 
4.23 mmol) were added a solution of 1,3,5-benzenetricarboxylic acid (0.269 g, 1.28 mmol) in dry DMF 
(20 mL) under argon. N-(tert-Butyloxycarbonyl)cystamine[1] (0.975g, 3.84 mmol) was dissolved in dry 
DMF (10 mL) and added the reaction mixture on an ice bath. After stirring at RT for 24 hrs the DMF was 
evaporated and the residue was dissolved in EtOAc (100 mL). The organic phase was sequentially 
washed with water (2x 50 mL), 1 M hydrochloric acid (3x 50 mL), saturated NaHCO3 solution (3x 50 
mL) and brine (1x 50 mL). The organic phase was dried (MgSO4) and concentrated in vacuo.  
Purification by dry column chromatography (5-50% EtOAc in petroleum ether) gave the desired product 
as white foam (0.537g, 46 %). 1H NMR (CDCl3): δ 8.30 (br. s, 3H), 7.55 (br. s, 3H), 5.21 (br. s, 3H), 3.77 
(q, J = 6.0 Hz, 6H), 3.46 (q, J = 6.0 Hz, 6H), 2.96 (t, J = 6.2 Hz, 6H), 2.84 (t, J = 6.5 Hz, 6H), 1.39 (s, 
27H); 13C NMR (CDCl3): δ 166.6, 156.2, 135.3, 128.7, 79.8, 39.7, 39.4, 38.3, 38.1, 28.5; MALDI-
HRMS: calcd. for C36H60N6NaO9S6+: 935.2638, found 935.2603. 
The Boc-protected target compound (0.311g, 0.34 mmol) was deprotected as described for Aa to 
give the TFA salt of Ca3 in quantitative yield as white foam, which was purified by HPLC (20% MeCN, 
Rt 4.6 min). 1H NMR (D2O): δ 8.27 (s, 3H), 3.79 (t, J = 6.3 Hz, 6H), 3.37 (t, J = 6.3 Hz, 6H), 3.03 (t, J = 
6.6 Hz, 12H); 13C NMR (D2O): δ 169.4, 135.5, 129.6, 39.4, 38.4, 36.8, 34.3; MALDI-HRMS: calcd. for 
C21H36N6NaO3S6+: 635.1065, found 635.1065. 
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Synthesis of side chains 
N,N,N´,N´-Tetramethylcystamine, b2 
 
1,2-Dimethylamino-ethanethiol hydrochloride (5.000 g, 35.3 mmol) was dissolved in MeOH (100 
mL) and titrated with 0.5 M iodine in MeOH until a yellow color persisted. The reaction was quenched 
with 10 % NaHSO3 solution (30 mL) to a colorless solution. MeOH was removed in vacuo and the 
remaining brownish water solution was added additional water (50 mL) and 2 M NaOH (aq.) until pH > 
10. The solution was continuously extracted from the water phase overnight with Et2O. The extract was 
concentrated to pink oil (3.33 g, 16 mmol), which was afterwards dissolved in dry Et2O (20 mL) and 
added 2.0 M HCl solution in Et2O (16 mL, ~32 mmol). This resulted in a white precipitate which was 
filtered and recrystallised from abs. EtOH to afford the disulphide as white crystals (3.942g, 80 %). 1H 
NMR (D2O, 300 MHz): δ 3.58 (t, J = 6.9 Hz, 4H), 3.14 (t, J = 6.9 Hz, 4H), 2.97 (s, 12 H); 13C NMR 
(D2O, 75 MHz): δ 56.2, 43.5, 31.2; EI MS m/z: 208 (100 %, M+). 
 
1,1'-(2,2'-Disulfanediylbis(ethane-2,1-diyl))diguanidine, c2 
 
Cystamine dihydrochloride (0.040 g, 0.18 mmol) and N,N’-di-Boc-N’’-trifluoromethanesulfonyl-
guanidine[2] (0.140 g, 0.36 mmol) were suspended in dry DCM (3 mL) under argon. Et3N (154 μL, 1.11 
mmol) was added and the mixture was stirred for 10 hrs at RT, during which the white solids dissolved. 
DCM (15 mL) was added and the organic phase was washed with 2 M NaHSO4 solution (10 mL), 
saturated NaHCO3 solution (10 mL), brine (15 mL) and dried (MgSO4). After concentration in vacuo the 
crude product was purified by flash column chromatography (Initially DCM, then EtOAc/PE 1:1 v/v) 
giving the desired tetra-Boc-bisguanidine compound as white solid (0.103 g, 91 %). 1H NMR (CDCl3, 
300 MHz): 11.47 (s, 2H), 8.62 (t, J = 5.4 Hz, 2H), 3.77 (q, J = 6.3 Hz, 4H), 2.88 (t, J = 6.3 Hz, 4H), 1.50 
(s, 36H); 13C NMR (CDCl3, 75 MHz): δ 163.7, 156.3, 153.3, 83.4, 79.5, 39.3, 37.2, 28.4, 28.2. 
The tetra-Boc-bisguanidine compound (0.072 g, 0.11 mmol) was dissolved in dry DCM (1.5 mL) 
under argon and TFA (300 μL) was added. The mixture was stirred for 1 h at RT and concentrated to give 
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the TFA salt of c2 as white solid in quantitative yield. 1H NMR (D2O, 300 MHz): δ 3.54 (t, J = 6.2 Hz, 
4H), 2.91 (t, J = 6.3 Hz, 4H); 13C NMR (D2O, 75 MHz): δ 163.9, 41.0, 37.2; MALDI-HRMS: calcd. for 
C6H16N6NaS2+: 259.0770, found 259.0769. 
 
Synthesis of the extracted compound 
1-(2-((2-(Acridin-9-ylamino)ethyl)disulfanyl)ethyl)guanidine, Ac 
 
The TFA salt of Aa (0.061 g, 0.11 mmol) and N,N’-Di-Boc-N’’-trifluoromethanesulfonyl-guanidine 
(0.041 g, 0.11 mmol) were dissolved in dry DCM (1 mL) under argon and Et3N (30 μL, 0.22 mmol) was 
added. The mixture was stirred for 2 hrs at RT and then washed with 2 M NaHSO4 solution (2x 2 mL), 
saturated NaHCO3 solution (2x 2 mL) and brine (2 mL). The organic phase was concentrated and purified 
by flash column chromatography (EtOAc/MeOH 8:1 v/v) to give yellow oil (0.037 g, 65%). 1H NMR 
(CDCl3, 300 MHz): 11.48 (s, 1H), 8.63 (s, 1H), 8.15 (m, 2H), 8.05 (m, 2H), 7.67 (m, 2H), 7.39 (m, 2H), 
7.25 (br s, 1H), 4.13 (m, 2H), 3.77 (m, 2H), 2.99 (m, 2H), 2.90 (m, 2H), 1.48, 1.47 (2x s, 18H); 13C NMR 
(CDCl3, 75 MHz): δ 163.6, 156.4, 153.4, 151.2, 130.3, 129.0, 123.7, 123.1, 117.7, 83.5, 79.6, 48.5, 39.4, 
39.1, 37.5, 28.4, 28.2. 
The yellow oil (0.0127 g, 0.002 mmol) was dissolved in dry DCM (0.3 mL) under argon and TFA 
(0.3 mL) was added. The mixture was stirred for 2 hrs at RT and concentrated to give the TFA salt of Ac 
as a yellow semi-solid in quantitative yield. The crude product was purified by HPLC (20% MeCN, Rt 
11.0 min). 1H NMR (D2O, 300 MHz): 8.01 (d, J = 8.7 Hz, 2H), 7.80 (t, J = 6.9 Hz, 2H), 7.43-7.38 (m, 
4H), 4.19 (t, J = 6.3 Hz, 2H), 3.36 (t, J = 6.3 Hz, 2H), 3.09 (t, J = 6.3 Hz, 2H), 2.71 (t, J = 6.3 Hz, 2H); 
13C NMR (D2O, 75 MHz): δ 163.7, 157.9, 139.5, 136.0, 125.1, 124.7, 118.9, 115.0, 47.8, 40.3, 36.7, 36.4; 
MALDI-HRMS: calcd. for C18H22N5S2+: 372.1311, found 372.1306. 
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Procedures for DCC experiments 
Oligonucleotides 
Oligonucleotides were synthesized by Sigma-Genosys (0.2 μmol scale) and received HPLC 
purified. All concentrations are expressed in strand molarity, using the nearest-neighbor approximation 
for the absorption coefficients of the unfolded species at 260 nm.[3] Two 5´-biotinylated oligonucleotides 
were used in the studies described: the human telomeric 5´-(biotin-d[(GT2AG2)5])-3´, and a random coil 
DNA control strand 5´-(biotin-d[(AGT2AG)5])-3´. The oligonucleotides were annealed in DCL buffer 
(150 mM KCl, 300 mM Tris-HCl, pH 7.4) by heating to 95 °C for 5 min and then slowly cooling to room 
temperature. After overnight incubation at 4 °C, the stock solutions were stored at -20 °C. 
 
DCL studies 
All solutions were prepared from degassed double distilled water. Stock solutions containing 1 mM 
of each scaffold component (Aa, Ba2 or Ca3), 100 mM of each side chain component (a2, b2 or c2) and of 
initiator a, and 50 mM of the alternative initiator dithiothreitol (DTT) were prepared in DCL buffer (150 
mM KCl, 300 mM Tris-HCl, pH 7.4). 
Scaffold stock solutions of Aa, (2.5 μL, 1 mM, 2.5 nmol), Ba2 (5.0 μL, 1 mM, 5.0 nmol) and Ca3 
(8.3 μL, 1 mM, 8.3 nmol), side chain stock solutions of a2 (3.85 μL, 100 mM, 385 nmol), b2 (5 μL, 100 
mM, 500 nmol) and c2 (5 μL, 100 mM, 500 nmol) and DCL buffer (18.35 μL) were mixed in an HPLC 
vial under a blanket of argon, and disulfide scrambling was initiated by addition of a (2 μL, 100 mM, 200 
nmol) or DTT (2 μL, 50 mM, 100 nmol) to give a total library volume of 50 μL. In templated DCL 
studies, a part of the DCL buffer solution was substituted with biotinylated G-quadruplex folded or 
random coil DNA stock solution to a final DNA concentration of 50 μM (2.5 nmol). The mixture was 
shaken gently in the capped HPLC vial. The DCL mixture was incubated for typically 3 hours, at which 
point the disulfide exchange was stopped by the addition of 10 μL of 1.7% aqueous TFA. The library 
solutions were analyzed by HPLC, and the individual peaks were analyzed by ESI-HRMS. 
The solution was added to 2 mg of magnetic streptavidin beads (Aureon biosystems, Streptavidin A-
beadsTM) and incubated at room temperature for 20 min. The beads were separated from solution with a 
magnet and washed with DCL buffer (3x 100 μL, pH 2). The washings were combined with the 
remaining library solution and analyzed by HPLC. The DNA was subsequently denatured by incubating 
 8
the beads with 0.05% TFA in water at 85 °C for 10 minutes (3x 200 µL), and the combined solutions 
from DNA denaturing were separately analyzed by HPLC. 
 
Confirming conservation of G-quadruplex folding in presence of the DCL 
Libraries containing biotinylated DNA were diluted with buffer (65 μL, pH 2) to give a 20 μM 
DNA solution, and corresponding DNA solutions with identical salt concentrations but without the DCL 
were prepared. CD spectra were recorded in a 1 mm quartz cuvette (J-815 CD-Spectrometer, JASCO, 
Figure S1).  
 
Figure S1. CD spectra of: 20 µM 5´-biotin-d[(GTTAGG)5] (blue: G-quadruplex; green: G-quadruplex + DCL mixture) 
and 20 µM 5´-biotin-d[(AGTTAG)5] (red: ssDNA; orange: ssDNA + DCL mixture) in DCL buffer. 
 
Assessing thermodynamic equilibrium 
Thermodynamic equilibrium is a requirement of regeneration of target-bound compounds in the 
mixture, and although it is not a requirement for the extraction procedure described here, it is still 
expected to have a beneficial influence on the outcome and to be important for the reproducibility of the 
library.[4]  
With the concentration of free thiol used here (4 mM), the mixture consistently reached a perfectly 
reproducible distribution of library members within 3 hours. Comparing a representative cysteamine 
initiated library with a DTT initiated library revealed that all peak integrals matched within 0.5%. The 
presence of free thiols in the mixture at equilibrium was ensured by Ellman’s test.[5]   
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Library analysis 
Table S1. UV-VIS absorbances for initial compounds relative to 245 nm. 
 245 nm 254 nm 285 nm 420 nm 
Aa 100 217 37 58 
Ba2 100 81 43 -- 
Ca3 100 65 7 -- 
 
Table S2. Analysis of library mixture incubated without DNA. 
 Peak Peak integrals a Peak absorption ratios b   % library composition c m/z Formula Cmpd. 
# 245 nm 254 nm 285 nm 420 nm 245 nm 254 nm 285 nm 420 nm Scaffold 245 nm 254 nm 285 nm Average Calcd. Found     
1 4,1750 2,6680 0,3308   100 64 8 -- C 4,4 4,5 4,4 4,4 635,1065 635,1135 C21H36N6NaO3S6+ Ca3 
2 3,3648 2,7202 1,5457   100 81 46 -- B 4,2 4,3 4,1 4,2 458,0783 458,0783 C15H25N5NaO2S4+ Ba2 
3 4,6287 2,9969 0,3760   100 65 8 -- C 4,9 5,0 5,0 5,0 641,1559 641,1565 C23H41N6O3S6+ Ca2b 
4 7,2687 5,8577 3,2720   100 81 45 -- B 9,1 9,3 8,6 9,0 464,1277 464,1295 C17H30N5O2S4+ Bab 
5 6,8821 15,1457 2,6192 4,2438 100 220 38 62 A 6,6 6,9 6,2 6,6 330,1093 330,1069 C17H20N3S2+ Aa 
6 3,8260 2,3954 0,3060   100 63 8 -- C 4,0 4,0 4,1 4,1 669,1872 669,1843 C25H45N6O3S6+ Cab2 
7 1,5515 1,0045 0,1153   100 65 7 -- C 1,6 1,7 1,5 1,6 655,1464 655,1458 C22H39N8O3S6+ Ca2c 
8 11,3723 19,3309 4,5514 4,3851 100 170 40 39 A+B 10,9 8,9 10,7 10,2      
            A     492,1590 492,1593 C19H34N5O2S4+ Ab 
            B     358,1406 358,1395 C19H24N3S2+ Bb2 
9 8,3955 5,3715 0,6881   100 64 8 -- C 8,9 9,0 9,2 9,0 683,1776 683,1765 C24H43N8O3S6+ Cabc 
10 7,0662 5,5733 3,1541   100 79 45 -- B 8,8 8,9 8,3 8,7 478,1181 478,1179 C16H28N7O2S4+ Bac 
11 4,4474 2,8187 0,3954   100 63 9 -- C 4,7 4,7 5,3 4,9 697,2185 697,2195 C27H49N6O3S6+ Cb2 
12 8,6172 18,8118 3,4217 5,3004 100 218 40 62 A 8,3 8,6 8,0 8,3 372,1311 372,1333 C18H22N5S2+ Ac 
13 7,5496 5,9556 3,5043   100 79 46 -- B 9,4 9,5 9,2 9,4 506,1495 506,1493 C18H32N7O2S4+ Bbc 
14 3,6530 2,3579 0,2790   100 65 8 -- C 3,9 4,0 3,7 3,9 697,1682 697,1675 C23H41N10O3S6+ Cac2 
15 4,2295 2,9060 0,3814   100 69 9 -- C 4,5 4,9 5,1 4,8 725,1995 725,1976 C25H45N10O3S6+ Cbc2 
16 3,6024 2,8949 1,6866   100 80 47 -- B 4,5 4,6 4,4 4,5 543,1292 543,1315 C17H30N9O2S4+ Bc3 
17 1,1849 0,7798 0,1411   100 66 12 -- C 1,3 1,3 1,9 1,5 370,0986 370,0941 C24H44N12O3S22+ Cc3 
a Crude integrals from HPLC chromatogram. 
b Absorption ratios relative to the 245 nm absorption.  
c Calculated from peak integral corrected for relative absorption (see table inserted in Figure 2a). 
  
Figure S2. All monitored wavelengths of the HPLC chromatogram from the supernatant after denaturation of G-
quadruplex 5´-(biotin-d[(GT2AG2)5])-3´. 
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Evaluation of compounds 
Circular Dichroism 
Samples were prepared to provide a Tris-HCl buffer (10 mM KCl, 10 mM Tris-HCl, pH 7.4) and a 
2 μM final concentration of oligonucleotide 5´-d[(G3(T2A3G3)3]-3´ in double distilled water. Test 
compounds were added from aqueous stock solutions to give a final concentration of 10 µM. All samples 
were annealed by heating to 95 °C for 10 min and slowly cooled to room temperature. CD spectra were 
recorded on a J-815 CD-Spectrometer (JASCO) using a quartz cell of 5 mm optical path length and 100 
nm/min scanning speed with a response time of 1 second in the wavelength ranges 220-320 nm with a 
data pitch of 0.1 nm. The final CD spectra are results of five averaged scans at 25 °C. Data were corrected 
for signal contributions due to the buffer. Tm experiments were performed with a heating rate of 0.2 
°C/min at a 295 nm wavelength with a data pitch of 0.1 °C in the temperature interval 25-95 °C. Tm 
curves were afterwards smoothened using a moving average method and normalized for comparison of 
data. 
 
Surface Plasmon Resonance 
Surface plasmon resonance (SPR) measurements were performed with a four-channel BIAcore 3000 
optical biosensor system (Biacore Inc.) equipped with a streptavidin-coated sensor chip. The oligomer 5'-
biotin-d[T7(T2AG3)4]-3' was heated at 95 °C for 5 min and annealed by slow cooling to form quadruplex 
in filtered and degassed buffer 20 mM Tris-HCl, 200 mM KCl, pH 7.4. The quadruplex was then 
immobilized (~400 RU) on flow cell 3. Similarly, 5'-biotin-d[(AGT2AG)5]-3' was immobilized (~400 
RU) on flow cell 2, leaving flow cell 1 and 4 as blank. Data from the blank flow cells were subtracted 
from the sample flow cells (2 and 3) to remove bulk responses caused by different refractive indexes of 
sample and running buffer. The baselines were adjusted to zero on the y (SPR response) axis and aligned 
to the injection time on the x (time) axis. 
DNA binding experiments were carried out in running buffer (filtered and degassed 20 mM 
KH2PO4, 150 mM KCl, 0.005 % surfactant P20, 0.5 mM EDTA, pH 7.4) at a flow rate of 20 μl/min. 
Ligand solutions at different concentrations (4, 12, 37, 111, 333 and 1000 nM) were prepared in degassed 
running buffer by serial dilutions from stock solution. These solutions were injected (80 µL/min for 120 
s) in random series to avoid any systematic error. Chip regeneration was performed using 1 M KCl. Data 
was analyzed using BIAevaluation 4.0.1. The curves were fitted to a 1:1 model (Figure S3). 
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Figure S3. The x-axis represents time (s) and the y-axis the observed response (RU). Sensorgrams are shown for the 
binding of ligands Aa (top) and Ac (bottom) to 5'-biotin-d[T7(T2AG3)4]-3'. 
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